TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Investor Lawsuit Filed Against Directors

  • Investors who purchased shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and currently hold any of those NASDAQ: RARE shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

An investor in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) filed a lawsuit against directors of Ultragenyx Pharmaceutical Inc over alleged excessive pay of certain directors. The plaintiff alleges alleging that the board has breached its fiduciary duty and engaged in self-dealing, unjust enrichment and waste in approving a compensation plan that grossly overcompensates ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: